Prospects and strategies for clinical tolerance

Area of Science:

• Immunology
• Transplantation Medicine
• Clinical Tolerance

Background:

• Chronic immunosuppression poses significant morbidity and mortality risks.
• Achieving clinical tolerance is a key goal in transplantation and autoimmune disease management.

Purpose of the Study:

• To define clinical (operational) tolerance.
• To explore the role of chimerism in tolerance induction.
• To review current strategies and principles for inducing clinical tolerance.

Main Methods:

• Literature review and synthesis of experimental and clinical data.
• Definition and discussion of microchimerism and macrochimerism.
• Analysis of bone marrow's role in tolerance.

Main Results:

• Chimerism, particularly from bone marrow, is central to experimental and clinical tolerance.
• Microchimerism and macrochimerism are defined and linked to transplantation outcomes.
• Existing clinical strategies for tolerance induction are identified and reviewed.

Conclusions:

• Understanding chimerism and bone marrow's function is vital for advancing clinical tolerance.
• Principles for inducing operational tolerance are elaborated based on current evidence.
• Further research into tolerance induction strategies is warranted to improve patient outcomes.